Allen Kaplan to Terfenadine
This is a "connection" page, showing publications Allen Kaplan has written about Terfenadine.
Connection Strength
0.295
-
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2005 Jun; 94(6):662-9.
Score: 0.252
-
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8.
Score: 0.043